Sartorius (OTCMKTS:SARTF) Stock Short Interest Drops 54.2%

Sartorius (OTCMKTS:SARTF – Get Free Report) was the target of a significant drop in short interest in the month of October. As of October 30th, there was short interest totaling 836 shares, a drop of 54.2% from the October 15th total of 1,827 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Sartorius Stock Performance

SARTF stock remained flat at $261.99 during midday trading on Monday. The business has a fifty day moving average price of $241.61 and a two-hundred day moving average price of $224.03. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89. Sartorius has a 1-year low of $181.58 and a 1-year high of $261.99. The company has a market cap of $8.97 billion, a P/E ratio of 121.85 and a beta of 0.98.

Sartorius Company Profile

(Get Free Report)

Sartorius is a life science company headquartered in Göttingen, Germany. Founded in 1870 as a precision-balance manufacturer, it has grown into a global supplier of technologies and services for biopharmaceutical production and laboratory research. The company’s bioprocessing products include filtration and fluid-management systems, single-use equipment, bioreactors, and technologies used in cell culture and purification. These solutions support the development and manufacture of biologic medicines, including vaccines and other advanced therapies.

See Also

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.